# FDA 483 - Women and Infants Institutional Review Board - January 03, 2017

Source: https://www.globalkeysolutions.net/records/483/women-and-infants-institutional-review-board/87693985-bb2a-4264-998d-8b0a44d83404

> FDA 483 for Women and Infants Institutional Review Board on January 03, 2017. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Women and Infants Institutional Review Board
- Inspection Date: 2017-01-03
- Product Type: Drugs
- Office Name: New England District Office
- Summary: The provided text describes the purpose and regulatory basis of an FDA Form 483, rather than detailing specific findings from a particular company inspection. This form is used to report objectionable conditions and practices observed during an establishment inspection, such as those indicating a food, drug, device, or cosmetic product may be adulterated or prepared under insanitary conditions. The regulatory framework for issuing these observations is Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21 USC 374(b)). The form serves to assist firms in complying with FDA regulations by highlighting issues that, in an inspector's judgment, indicate potential product contamination or health hazards. The specific company name, inspection dates, detailed violations, or any required corrective actions are not present in the provided text, as this content appears to be redacted.

## Related Officers

- [Chair of Review Board](https://www.globalkeysolutions.net/people/vivian-w-sung/707623e6-6036-4190-8676-80876318c174)
- [investigator](https://www.globalkeysolutions.net/people/victoria-m-daddeo/dbd92345-27c5-43fe-beb4-b1b5974bec05)

Company: https://www.globalkeysolutions.net/companies/women-and-infants-institutional-review-board/b31dacf3-b1e7-4836-9d30-f42a053a3ed9

Office: https://www.globalkeysolutions.net/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144